Explore / Clinical trial
Clinical trial

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer

Instituto Nacional de Cancerologia de MexicoCompletedPhase 1Started Sep 19, 201919 enrolledMexicoNCT04471818

Abstract

Major depression (MD) is a psychiatric disorder characterized by a persistent feeling of sadness, anhedonia or a decreased perception of pleasurable experiences, as well as appetite alterations and weight variations, sleep disorders, altered psychomotor skills, fatigue, guilt, decreased self-worth, suicidal thoughts and difficulty concentrating in a task (1). MD is a frequent complication in patients who are diagnosed with advanced cancer.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepressionPalliative care

Keywords

Major Depressive DisorderAdvanced Cancer

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.